For: |
Wang JX, He YL, Zhu ST, Yang S, Zhang ST. Aberrant methylation of the 3q25 tumor suppressor gene |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i37/4225.htm |
Number | Citing Articles |
1 |
Steven S Smith. Maintaining the unmethylated state. Clinical Epigenetics 2013; 5(1) doi: 10.1186/1868-7083-5-17
|
2 |
Daniel S. Peiffer, Noah P. Zimmerman, Li-Shu Wang, Benjamin W.S. Ransom, Steven G. Carmella, Chieh-Ti Kuo, Jibran Siddiqui, Jo-Hsin Chen, Kiyoko Oshima, Yi-Wen Huang, Stephen S. Hecht, Gary D. Stoner. Chemoprevention of Esophageal Cancer with Black Raspberries, Their Component Anthocyanins, and a Major Anthocyanin Metabolite, Protocatechuic Acid. Cancer Prevention Research 2014; 7(6): 574 doi: 10.1158/1940-6207.CAPR-14-0003
|
3 |
Roberto Ronca, Patrizia Alessi, Daniela Coltrini, Emanuela Di Salle, Arianna Giacomini, Daria Leali, Michela Corsini, Mirella Belleri, Chiara Tobia, Cecilia Garlanda, Elisa Bonomi, Regina Tardanico, William Vermi, Marco Presta. Long pentraxin‐3 as an epithelial–stromal fibroblast growth factor‐targeting inhibitor in prostate cancer. The Journal of Pathology 2013; 230(2): 228 doi: 10.1002/path.4181
|
4 |
Lehang Lin, Xu Cheng, Dong Yin. Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.549850
|
5 |
Andrea Doni, Matteo Stravalaci, Antonio Inforzato, Elena Magrini, Alberto Mantovani, Cecilia Garlanda, Barbara Bottazzi. The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00712
|
6 |
Manuel Scimeca, Rita Bonfiglio, Nicoletta Urbano, Chiara Cerroni, Lucia Anemona, Manuela Montanaro, Sara Fazi, Orazio Schillaci, Alessandro Mauriello, Elena Bonanno. Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition. Urologic Oncology: Seminars and Original Investigations 2019; 37(5): 297.e19 doi: 10.1016/j.urolonc.2019.02.013
|
7 |
Daniel S. Peiffer, Li-Shu Wang, Noah P. Zimmerman, Benjamin W.S. Ransom, Steven G. Carmella, Chieh-Ti Kuo, Jo-Hsin Chen, Kiyoko Oshima, Yi-Wen Huang, Stephen S. Hecht, Gary D. Stoner. Dietary Consumption of Black Raspberries or Their Anthocyanin Constituents Alters Innate Immune Cell Trafficking in Esophageal Cancer. Cancer Immunology Research 2016; 4(1): 72 doi: 10.1158/2326-6066.CIR-15-0091
|
8 |
Sébastien Jaillon, Eduardo Bonavita, Stefania Gentile, Marcello Rubino, Ilaria Laface, Cecilia Garlanda, Alberto Mantovani. The Long Pentraxin PTX3 as a Key Component of Humoral Innate Immunity and a Candidate Diagnostic for Inflammatory Diseases. International Archives of Allergy and Immunology 2014; 165(3): 165 doi: 10.1159/000368778
|
9 |
Francesco Fornai, Albino Carrizzo, Michela Ferrucci, Antonio Damato, Francesca Biagioni, Anderson Gaglione, Annibale Alessandro Puca, Carmine Vecchione. Brain diseases and tumorigenesis: The good and bad cops of pentraxin3. The International Journal of Biochemistry & Cell Biology 2015; 69: 70 doi: 10.1016/j.biocel.2015.10.017
|
10 |
Chao Liu, Yao Yao, Wei Wang. Pentraxin-3 as a prognostic marker in patients with small-cell lung cancer. Medical Oncology 2014; 31(10) doi: 10.1007/s12032-014-0207-1
|
11 |
Hao Wang, Stephen J. Atkins, Roshini Fernando, Rui-Li Wei, Terry J. Smith. Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts. Endocrinology 2015; 156(11): 4336 doi: 10.1210/en.2015-1399
|
12 |
Andrea Doni, Cecilia Garlanda, Alberto Mantovani. Innate immunity, hemostasis and matrix remodeling: PTX3 as a link. Seminars in Immunology 2016; 28(6): 570 doi: 10.1016/j.smim.2016.10.012
|
13 |
Kholood Abid Janjua, Raheem Shahzad, Adeeb Shehzad. Cancer Biomarkers in Diagnosis and Therapeutics. 2022; : 277 doi: 10.1007/978-981-16-5759-7_11
|
14 |
Alberto Mantovani, Sonia Valentino, Stefania Gentile, Antonio Inforzato, Barbara Bottazzi, Cecilia Garlanda. The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules. Annals of the New York Academy of Sciences 2013; 1285(1): 1 doi: 10.1111/nyas.12043
|
15 |
Clémence Thomas, Whitney Henry, Benjamin G. Cuiffo, Anthony Y. Collmann, Elisabetta Marangoni, Vanessa Benhamo, Manoj K. Bhasin, Cheng Fan, Laetitia Fuhrmann, Albert S. Baldwin, Charles Perou, Anne Vincent-Salomon, Alex Toker, Antoine E. Karnoub. Pentraxin-3 is a PI3K signaling target that promotes stem cell–like traits in basal-like breast cancers. Science Signaling 2017; 10(467) doi: 10.1126/scisignal.aah4674
|
16 |
Yu‐Wei Hsiao, Jhih‐Ying Chi, Chien‐Feng Li, Lei‐Yi Chen, Yi‐Ting Chen, Hsin‐Yin Liang, Yu‐Chih Lo, Jhen‐Yi Hong, Chin‐Pin Chuu, Liang‐Yi Hung, Jyun‐Yi Du, Wen‐Chang Chang, Ju‐Ming Wang. Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple‐negative breast cancers. Clinical and Translational Medicine 2022; 12(1) doi: 10.1002/ctm2.724
|
17 |
Yoshifumi Baba, Masayuki Watanabe, Hideo Baba. A review of the alterations in DNA methylation in esophageal squamous cell carcinoma. Surgery Today 2013; 43(12): 1355 doi: 10.1007/s00595-012-0451-y
|
18 |
Wanli Yang, Yu Han, Xinhui Zhao, Lili Duan, Wei Zhou, Xiaoqian Wang, Gaokai Shi, Yinggang Che, Yujie Zhang, Jinqiang Liu, Hongwei Zhang, Qingchuan Zhao, Liu Hong, Daiming Fan. Advances in prognostic biomarkers for esophageal cancer. Expert Review of Molecular Diagnostics 2019; 19(2): 109 doi: 10.1080/14737159.2019.1563485
|
19 |
Eduardo Bonavita, Stefania Gentile, Marcello Rubino, Virginia Maina, Roberto Papait, Paolo Kunderfranco, Carolina Greco, Francesca Feruglio, Martina Molgora, Ilaria Laface, Silvia Tartari, Andrea Doni, Fabio Pasqualini, Elisa Barbati, Gianluca Basso, Maria Rosaria Galdiero, Manuela Nebuloni, Massimo Roncalli, Piergiuseppe Colombo, Luigi Laghi, John D. Lambris, Sébastien Jaillon, Cecilia Garlanda, Alberto Mantovani. PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer. Cell 2015; 160(4): 700 doi: 10.1016/j.cell.2015.01.004
|
20 |
Damiano Chiari, Barbara Pirali, Vittoria Perano, Roberto Leone, Alberto Mantovani, Barbara Bottazzi. The crossroad between autoimmune disorder, tissue remodeling and cancer of the thyroid: The long pentraxin 3 (PTX3). Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1146017
|
21 |
Barbara Bottazzi, Antonio Inforzato, Massimo Messa, Marialuisa Barbagallo, Elena Magrini, Cecilia Garlanda, Alberto Mantovani. The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling. Journal of Hepatology 2016; 64(6): 1416 doi: 10.1016/j.jhep.2016.02.029
|
22 |
Cecilia Garlanda, Barbara Bottazzi, Elena Magrini, Antonio Inforzato, Alberto Mantovani. PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer. Physiological Reviews 2018; 98(2): 623 doi: 10.1152/physrev.00016.2017
|
23 |
Shingo Tsuji, Yutaka Midorikawa, Motoaki Seki, Tadatoshi Takayama, Yasuyuki Sugiyama, Hiroyuki Aburatani. Network-based analysis for identification of candidate genes for colorectal cancer progression. Biochemical and Biophysical Research Communications 2016; 476(4): 534 doi: 10.1016/j.bbrc.2016.05.158
|
24 |
Hao Zhang, Ruixuan Wang, Zeyu Wang, Wantao Wu, Nan Zhang, Longbo Zhang, Jason Hu, Peng Luo, Jian Zhang, Zaoqu Liu, Songshan Feng, Yun Peng, Zhengzheng Liu, Quan Cheng. Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role. Biomedicine & Pharmacotherapy 2022; 156: 113783 doi: 10.1016/j.biopha.2022.113783
|
25 |
Elena Magrini, Alberto Mantovani, Cecilia Garlanda. The Dual Complexity of PTX3 in Health and Disease: A Balancing Act?. Trends in Molecular Medicine 2016; 22(6): 497 doi: 10.1016/j.molmed.2016.04.007
|
26 |
Arianna Giacomini, Gaia Cristina Ghedini, Marco Presta, Roberto Ronca. Long pentraxin 3: A novel multifaceted player in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018; 1869(1): 53 doi: 10.1016/j.bbcan.2017.11.004
|
27 |
Manuela Cabiati, Melania Gaggini, Paolo De Simone, Silvia Del Ry. Do pentraxin 3 and neural pentraxin 2 have different facet function in hepatocellular carcinoma?. Clinical and Experimental Medicine 2021; 21(4): 555 doi: 10.1007/s10238-021-00714-y
|
28 |
Wei‐Chun Weng, Yi‐Hsien Hsieh, Chia‐Yen Lin, Yu‐Fan Liu, Shih‐Chi Su, Shian‐Shiang Wang, Shun‐Fa Yang. Functional variants of the pentraxin 3 gene are associated with the metastasis and progression of prostate cancer. Journal of Cellular and Molecular Medicine 2024; 28(16) doi: 10.1111/jcmm.70041
|
29 |
Dan Ma, Ye Zong, Sheng-Tao Zhu, Yong-Jun Wang, Peng Li, Shu-Tian Zhang. Inhibitory Role of Pentraxin-3 in Esophageal Squamous Cell Carcinoma. Chinese Medical Journal 2016; 129(18): 2233 doi: 10.4103/0366-6999.189921
|
30 |
Teyueh Lin, Hong Guo, Xiaoli Chen. Pentraxin 3 Regulates miR‐21 Expression and Secretion in Brown Adipocytes During Lipopolysaccharide‐Induced Inflammation. Obesity 2020; 28(2): 323 doi: 10.1002/oby.22701
|
31 |
Zijian Zhou, Xuan Zhou, Yuanyuan Yang, Lujia Wang, Zhong Wu. Pan-Cancer Analysis of Pentraxin 3: A Potential Biomarker of COVID-19. Cancers 2022; 14(18): 4438 doi: 10.3390/cancers14184438
|
32 |
Kenji Daigo, Antonio Inforzato, Isabella Barajon, Cecilia Garlanda, Barbara Bottazzi, Seppo Meri, Alberto Mantovani. Pentraxins in the activation and regulation of innate immunity. Immunological Reviews 2016; 274(1): 202 doi: 10.1111/imr.12476
|
33 |
Duo Li, Zhaozhao Hao, Yandong Nan, Yanwei Chen. Role of long pentraxin PTX3 in cancer. Clinical and Experimental Medicine 2023; 23(8): 4401 doi: 10.1007/s10238-023-01137-7
|
34 |
Marco Erreni, Angelo A. Manfredi, Cecilia Garlanda, Alberto Mantovani, Patrizia Rovere‐Querini. The long pentraxin PTX3: A prototypical sensor of tissue injury and a regulator of homeostasis. Immunological Reviews 2017; 280(1): 112 doi: 10.1111/imr.12570
|
35 |
Cecilia Garlanda, Sebastien Jaillon, Andrea Doni, Barbara Bottazzi, Alberto Mantovani. PTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition. Current Opinion in Immunology 2016; 38: 39 doi: 10.1016/j.coi.2015.11.002
|